Comparing the Mortality Risk between Metabolic Dysfunction-Associated Fatty Liver Disease and Non-Alcoholic Fatty Liver Disease

정한나 ,  정창희

Diabetes and Metabolism Journal

2023 .03

Changing the nomenclature from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease is more than a change in terminology

Eileen Lau ,  el Yoon ,  Dae Won Jun

Clinical and Molecular Hepatology

2023 .04

Correspondence on Letter regarding “Waiting for the changes after the adoption of steatotic liver disease”

Eileen L. Yoon ,  Dae Won Jun

Clinical and Molecular Hepatology

2024 .01

Similar respiratory function including chronic obstructive pulmonary disease between non-alcoholic fatty liver disease and metabolic dysfunction-associated steatotic liver disease

Tsubasa Tsutsumi ,  Dan Nakano ,  Machiko Kawaguchi 외 3명

Clinical and Molecular Hepatology

2024 .04

비만 소아청소년의 간기능 이상과 대사위험인자와의 관계

추지은 ,  권은주 ,  나은희

보건교육건강증진학회지

2017 .09

Change in fatty liver status and 5-year risk of incident metabolic syndrome: a retrospective cohort study

한은나 ,  정은선 ,  이정인 외 6명

Clinical Hypertension

2015 .01

Clinical and Histologic Features of Patients with Biopsy-Proven Metabolic Dysfunction-Associated Fatty Liver Disease

Huang Shang-Chin ,  Su Hau-Jyun ,  Kao Jia-Ho 외 6명

Gut and Liver

2021 .01

From nonalcoholic fatty liver disease to metabolic-associated fatty liver disease: Big wave or ripple?

Seong Hee Kang ,  Yu ,  i Cho 외 3명

Clinical and Molecular Hepatology

2021 .01

Effects of interleukin-17 inhibitors on hepatic fibrosis index in patients with psoriasis and metabolic dysfunction- associated fatty liver disease: Directed acyclic graphs

Sao ,  i Takamu ,  a 외 13명

Clinical and Molecular Hepatology

2022 .04

MAFLD enhances clinical practice for liver disease in the Asia-Pacific region

Takumi Kawaguchi ,  Tsubasa Tsutsumi ,  Dan Nakano 외 6명

Clinical and Molecular Hepatology

2022 .04

Non-invasive imaging biomarkers for liver steatosis in non-alcoholic fatty liver disease: present and future

Asako Nogami ,  Masato Yoneda ,  Michihi 외 8명

Clinical and Molecular Hepatology

2023 .02

Non-obese or lean nonalcoholic fatty liver disease matters, but is it preventable or inevitable in light of its risk factors?

Heejoon Jang ,  Won Kim

Clinical and Molecular Hepatology

2023 .04

Probiotics for treatment of nonalcoholic fatty liver disease: It is worth a try

Tian-Yi Ren ,  Xiao-Yan Li ,  Jian-Gao Fan

Clinical and Molecular Hepatology

2021 .01

Three-Step Algorithm for Screening High-Risk Group of Metabolic Dysfunction-Associated Steatotic Liver Disease in General Population

Oh Joo Hyun ,  Jun Dae Won

Gut and Liver

2024 .03

Chronic hepatitis B with concurrent metabolic dysfunction-associated fatty liver disease: Challenges and perspectives

Shang-Chin Huang ,  Chun-Jen Liu

Clinical and Molecular Hepatology

2023 .04

Beyond Liver Disease: Non-Alcoholic Fatty Liver Disease and Advanced Liver Fibrosis in Kidney Disease

한유진

Diabetes and Metabolism Journal

2022 .07

Fatty Liver & Diabetes Statistics in Korea: Nationwide Data 2009 to 2017

한유진 ,  한경도 ,  이용호 외 4명

Diabetes and Metabolism Journal

2023 .05

Association of nonalcoholic fatty liver disease with incident dementia later in life among elderly adults

Byoung Seok Ye

Clinical and Molecular Hepatology

2022 .07

Steatotic liver disease: Know your enemies

Lung-Yi Mak

Clinical and Molecular Hepatology

2024 .04